Comments
Loading...

Nouveau Life Pharma Analyst Ratings

NOUVOTCPK
Logo brought to you by Benzinga Data
$0.000001
0.000.00%
At close: -

Nouveau Life Pharma Analyst Ratings and Price Targets | OTC:NOUV | Benzinga

Nouveau Life Pharma Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Nouveau Life Pharma Corp from these most-recent analyst ratings.

Analyst Ratings for Nouveau Life Pharma

Buy NowGet Alert
No data available to display

FAQ

Q

What is the target price for Nouveau Life Pharma (NOUV) stock?

A

There is no price target for Nouveau Life Pharma

Q

What is the most recent analyst rating for Nouveau Life Pharma (NOUV)?

A

There is no analyst for Nouveau Life Pharma

Q

When was the last upgrade for Nouveau Life Pharma (NOUV)?

A

There is no last upgrade for Nouveau Life Pharma

Q

When was the last downgrade for Nouveau Life Pharma (NOUV)?

A

There is no last downgrade for Nouveau Life Pharma.

Q

When is the next analyst rating going to be posted or updated for Nouveau Life Pharma (NOUV)?

A

There is no next analyst rating for Nouveau Life Pharma.

Q

Is the Analyst Rating Nouveau Life Pharma (NOUV) correct?

A

There is no next analyst rating for Nouveau Life Pharma.

Browse analyst ratings and price targets on all stocks.